Science for ME: News in Brief
15 - 21 Jun 2026
đ§” of highlighted #MECFS and #LongCovid research papers discussed in the last week on the Science for ME forum.
@mecfs
https://s4me.info/threads/news-in-brief-june-2026.50572/post-701886
Science for ME: News in Brief
15 - 21 Jun 2026
đ§” of highlighted #MECFS and #LongCovid research papers discussed in the last week on the Science for ME forum.
@mecfs
https://s4me.info/threads/news-in-brief-june-2026.50572/post-701886
Systems neuroendocrinology in ME/CFS and long COVID: a chronobiological framework for hormone-based research â Thomas et al
"ME/CFS and Long COVID are complex, fluctuating illnesses in which neuroendocrine findings remain inconsistent when examined through isolated, static hormone measurements."
https://www.sciencedirect.com/science/article/abs/pii/S0091302226000385
Higher-order brain processes, rather than early processing, underlie sensory problems in ME/CFS: evidence from ERPs â Kumar et al
"we asked if the early bottom-up sensory gating, which prevents information overload by suppressing trivial and repetitive sensory information (P50, N100), and/or later cognitive control top-down processes (N200, P300) that regulate sensory processing, may be affected in ME/CFS."
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1842841/full
Disrupted Glymphatic Function and Its Relationship with Sleep and Cognitive Impairment in ME/CFS Assessed via DTI-ALPS â Thapaliya et al
"we found that only the right hemisphere DTI-ALPS index was significantly lower in ME/CFS compared to healthy controls, with no differences observed in the left hemisphere."
https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1875420/full
Gastrointestinal symptoms correlate with core clinical features and systemic inflammation in myalgic encephalomyelitis/chronic fatigue syndrome â Brown et al
"Plasma CRP levels were significantly higher in ME/CFS patients with increased GI symptom frequency (combined GI frequency score >10) (P = 0.002)."
https://link.springer.com/article/10.1186/s12967-026-08442-1

Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness marked by fatigue, cognitive impairment, and post-exertional malaise. Gastrointestinal (GI) symptoms are frequently reported, yet their relationship to central features of the illness and biological correlates remains poorly understood. Objectives We aimed to characterize GI symptom burden in ME/CFS and evaluate its associations with core clinical features and specific immune and inflammatory markers, with attention to potential gut-related contributions to disease expression. Methods GI symptoms and 49 additional symptoms across nine domains were assessed in 116 ME/CFS patients and 80 matched controls. Plasma C-reactive protein (CRP) and antibodies against dietary and microbial antigens were measured as indicators of systemic inflammation and putative gut-derived antigen exposure. Results ME/CFS patients reported significantly elevated GI symptom frequency and severity compared with controls, with 53% of ME/CFS patients versus 8% of controls reporting a prior diagnosis of irritable bowel syndrome. GI symptom burden correlated with fatigue, cognitive difficulties, flu-like symptoms, pain, sleep disturbances, neurological complaints, and sensory sensitivities, independent of illness duration. CRP levels were higher in patients with greater GI symptoms and correlated with GI, fatigue, musculoskeletal pain, and flu-like symptom burden. Patients with greater flu-like symptom expression exhibited higher IgM responses to dietary gliadin and bacterial lipopolysaccharide. These associations were not detected in controls. Conclusions GI symptoms are a prominent, clinically relevant dimension of ME/CFS, associated with broader symptom burden and inflammatory heterogeneity. These findings highlight the relevance of gut-related and immune processes in ME/CFS and underscore the value of incorporating GI symptom assessment in translational studies to help refine mechanistic understanding and improve therapeutic stratification.
Development and initial content validation of the Vienna Post-Exertional Malaise Questionnaire: an iterative mixed-methods study â Pimminger et al
Objectives Post-exertional malaise (PEM) is increasingly understood not as a singular symptom but as a multidimensional exertion-response pattern involving diverse triggers, variable onset, and prolonged recovery. This study aimed to develop and content-validate the Vienna Post-Exerti...
ME/CFS and/or Long Covid in Aotearoa New Zealand: results from a food insecurity survey â Dey et al
"This work supports the need for ME/CFS and LC to be identified as a disability for the purposes of social service and income support provision, which is currently not the case in Aotearoa | New Zealand."
https://www.tandfonline.com/doi/abs/10.1080/21641846.2026.2688051
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial â Stortz et al
"No clinically relevant difference was found between IA and sham treatment for changes in either post-COVID symptom severity related to PCFS or the severity of fatigue based on MFI-20, CFS and Bell Scale"
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(26)00156-0/abstract
Persistent Muscle Dysfunction and Symptom Burden in Post-COVID Syndrome: A Prospective Longitudinal Study â Wunderle et al
"patients exhibited significantly lower Fmean, elevated muscular fatigability (Fatigue Ratio), and reduced recovery capacity compared with matched COVID-19 recovered controls at both [Baseline] and [Followup]." "objective muscle impairments remained largely stable over the six-month observation period"
Background Post-COVID syndrome (PCS) is characterized by persistent heterogeneous symptoms after SARS-CoV-2 infection, yet objective biomarkers for symptom severity and longitudinal disease trajectories remain limited. We aimed to characterize muscle function over time in PCS and exam...
Muscle fatigue in patients with severe long COVID: A 2-year follow-up study â Almeida et al
Follow-up of hospitalised patients. "The dissociation between preserved gross morphology and microscopic pathology suggests that advanced imaging and biopsy techniques may be necessary to fully characterize muscle changes in patients with long COVID, though this was beyond the scope of the present study."
Identifying electroencephalography (EEG)-based biomarkers of Long COVID â SĂĄnchez
"Following the [Motor Learning] task, Long COVID individuals exhibited a smaller increase in global efficiency and a larger decrease in participation coefficient relative to healthy controls." "This suggests that the brain's ability to reorganize its network in response to cognitive demands may be a sensitive marker of Long COVID-related fatigue and cognitive impairment."
https://mcgill.scholaris.ca/items/031cf911-4bca-473c-9f37-8b94853c6d55
La COVID longue est une condition marquĂ©e par des symptĂŽmes persistants tels que la fatigue, les troubles cognitifs et le malaise post-effort (PEM), de plus en plus reconnus comme des consĂ©quences neurologiques de la maladie. Comprendre les bases neuronales de ces symptĂŽmes est essentiel pour identifier des biomarqueurs, guider lâĂ©valuation clinique et dĂ©velopper des interventions ciblĂ©es. Cette thĂšse a utilisĂ© lâĂ©lectroencĂ©phalographie (EEG) Ă haute densitĂ© afin dâexaminer la relation entre lâactivitĂ© cĂ©rĂ©brale et les symptĂŽmes persistants chez des personnes atteintes de COVID longue, en se concentrant sur lâactivitĂ© liĂ©e au mouvement ainsi quâau repos. Les analyses ont portĂ© sur les caractĂ©ristiques spectrales, les oscillations dans la bande bĂȘta, la connectivitĂ© fonctionnelle, les mĂ©triques issues de la thĂ©orie des graphes (GTA) et la complexitĂ© neuronale, afin de caractĂ©riser les altĂ©rations cĂ©rĂ©brales sous-jacentes.Vingt individus atteints de COVID longue et vingt tĂ©moins sains appariĂ©s en Ăąge et en sexe ont participĂ© Ă lâĂ©tude. Le protocole comprenait des enregistrements de lâactivitĂ© cĂ©rĂ©brale au repos et lors de contractions soutenues de la main, suivis dâune tĂąche dâapprentissage moteur (ML) destinĂ©e Ă accroĂźtre la charge cognitive, puis dâenregistrements post-tĂąche au repos et lors de contractions de la main.Pour examiner la dynamique oscillatoire du cortex sensorimoteur (SMC), la dĂ©synchronisation bĂȘta liĂ©e au mouvement (MRBD) et le rebond bĂȘta post-mouvement (PMBR) ont Ă©tĂ© quantifiĂ©s Ă partir des enregistrements EEG lors des contractions. Ces mesures reflĂštent respectivement la prĂ©paration motrice, lâexĂ©cution et lâinhibition aprĂšs le mouvement. Les propriĂ©tĂ©s pĂ©riodiques alpha, associĂ©es Ă lâexcitabilitĂ© corticale et Ă lâinhibition fonctionnelle, ont Ă©tĂ© Ă©valuĂ©es Ă partir des enregistrements EEG au repos avec les yeux ouverts. Les participants COVID longue ont prĂ©sentĂ© un PMBR significativement rĂ©duit ainsi quâun ralentissement de la frĂ©quence centrale alpha dans le SMC. Un PMBR plus faible Ă©tait associĂ© Ă des plaintes cognitives accrues, tandis quâune frĂ©quence centrale alpha plus lente Ă©tait associĂ©e Ă une fatigue et Ă des difficultĂ©s cognitives plus marquĂ©es.Afin dâapprofondir lâinvestigation de lâensemble du cerveau, les paramĂštres spectraux, la connectivitĂ© fonctionnelle, les mĂ©triques de GTA et les mesures de complexitĂ© ont Ă©tĂ© calculĂ©s Ă partir des enregistrements EEG au repos avec les yeux fermĂ©s, rĂ©alisĂ©s avant et aprĂšs la tĂąche ML. Ces analyses renseignent sur lâorganisation du cerveau en tant que rĂ©seau, lâefficacitĂ© de sa communication et la flexibilitĂ© de ses signaux. Ă lâĂ©tat de base, les participants COVID longue ont montrĂ© une largeur de bande alpha significativement plus Ă©troite que celle des tĂ©moins. AprĂšs la tĂąche ML, ils ont prĂ©sentĂ© une augmentation plus faible de lâefficacitĂ© globale et une diminution plus marquĂ©e du coefficient de participation par rapport aux tĂ©moins. Plusieurs des mesures EEG Ă©taient associĂ©es aux symptĂŽmes et aux performances cognitives, suggĂ©rant que la capacitĂ© du cerveau Ă rĂ©organiser son rĂ©seau face Ă une charge cognitive accrue pourrait constituer un marqueur sensible de la fatigue et des troubles cognitifs liĂ©s Ă la COVID longue.En intĂ©grant les rĂ©sultats Ă diffĂ©rents niveaux spatiaux et fonctionnels, cette thĂšse caractĂ©rise les patrons dâactivitĂ© corticale associĂ©s Ă la COVID longue, rĂ©vĂ©lant un ralentissement spectral, une modulation oscillatoire rĂ©duite et une reconfiguration altĂ©rĂ©e du rĂ©seau aprĂšs une charge cognitive. Ces rĂ©sultats offrent des pistes prometteuses pour lâidentification de biomarqueurs EEG de la COVID longue et ouvrent la voie au dĂ©veloppement dâinterventions thĂ©rapeutiques ciblĂ©es
Genetic association between LONG COVID and TMPRSS2 polymorphisms (rs12329760 and rs2070788) in Brazilian healthcare professionals â Telles et al
"carriers of the G allele in this model have an odds ratio of 1.73 times more likely to experience memory and concentration problems." "This result supports the relationship between this polymorphism and the severity of COVID-19 in the acute phase"

Long COVID syndrome has a multifactorial cause that is not fully understood and may be influenced by both external and intrinsic factors. In this context, a ...
Long COVID risk by pre-infection symptoms and functional status: A retrospective cohort study of data from the All of Us Research Program â Kehl-Floberg et al
"there were no significant differences in risk of long COVID based on either pre-infection total incidences of long COVID symptoms (compared to the average of 4) or pre-infection functional impairment."
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330793

Importance Over seven million U.S. adults experience persistent health issues after COVID-19, known as âlong COVIDâ. Although multiple guidelines recommend the inclusion of functional status in long COVID diagnostic criteria, more evidence is needed to guide this recommendation. This study explored the adjusted odds of developing long COVID by pre-infection symptoms and functional status, and the feasibility of estimating functional status using health records data. Design & Methods Retrospective cohort study of U.S. adults with history of COVID-19 enrolled in a multicenter national cohort study through July 2022 (All of Us Controlled Tier CDR 7.0), using diagnostic, procedure, and billing codes from the health record, and baseline survey responses. The risk of long COVID was estimated using logistic regression by pre-infection (â5 years) incidences of (a) at least one symptom common in long COVID, and (b) functional impairment, and adjusted for disease and demographic characteristics. Results n = 65,464 met inclusion criteria; n = 40,655 had post-infection occurrences of at least one symptom (long COVID group), n = 24,809 had none (recovered). Adjusted odds ratios of developing long COVID increased with older age, female sex, Black racial identity, earlier variant, non-vaccination, lower pre-infection self-reported mental and cognitive health, and number of pre-infection symptoms. Adjusted odds were not significantly affected by any single pre-infection symptom, self-rated physical ability, or EHR-derived indicators of prior functional impairment. Conclusions In this model, there were no significant differences in risk of long COVID based on either pre-infection total incidences of long COVID symptoms (compared to the average of 4) or pre-infection functional impairment. This suggests that long COVID was associated with a change from baseline functioning and health, including in people with pre-infection incident symptoms and functional impairments. The impacts of co-occurring pre-infection symptoms requires further investigation. Both harmonized electronic health records data and patient-reported outcomes contribute important data for developing the diagnostic utility of functional status changes in long COVID.